Cloning and Mutagenesis Market Share & Statistics, 2024-2032

Cloning and Mutagenesis Market - By Product (Cloning Kits, Mutagenesis Kits), Technology (Topo PCR Cloning, Site-directed Mutagenesis), End-use (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes) & Forecast 2024 - 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Forecast parameters

1.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data Sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Public sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Cloning and mutagenesis industry 3600 synopsis, 2018 &ndash; 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Regional trends

2.1.3&nbsp;&nbsp;&nbsp; Product trends

2.1.4&nbsp;&nbsp;&nbsp; Technology trends

2.1.5&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Cloning and Mutagenesis Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Growing demand for precision medicine

3.2.1.2&nbsp;&nbsp;&nbsp;Rising demand for genetically modified products

3.2.1.3&nbsp;&nbsp;&nbsp;Advancements in genetic engineering techniques

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;High maintanance cost of cloning and mutagenesis tools &amp; instruments

3.2.2.2&nbsp;&nbsp;&nbsp;Limited availability of qualified researchers

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By product

3.3.2&nbsp;&nbsp;&nbsp; By technology

3.3.3&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5.1&nbsp;&nbsp;&nbsp; U.S.

3.5.2&nbsp;&nbsp;&nbsp; Europe

3.6&nbsp;&nbsp;&nbsp; Technology lndscape

3.7&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Cloning and Mutagenesis Market Size and Forecast, By Product (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by product

5.2&nbsp;&nbsp;&nbsp; Cloning kits

5.3&nbsp;&nbsp;&nbsp; Mutagenesis kits

5.4&nbsp;&nbsp;&nbsp; Other products

Chapter 6&nbsp;&nbsp;&nbsp;Cloning and Mutagenesis Market Size and Forecast, By Technology (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by technology

6.2&nbsp;&nbsp;&nbsp; TOPO PCR cloning

6.3&nbsp;&nbsp;&nbsp; Blunt end cloning

6.4&nbsp;&nbsp;&nbsp; Seamless cloning

6.5&nbsp;&nbsp;&nbsp; Site-directed mutagenesis

6.6&nbsp;&nbsp;&nbsp; Other technologies

Chapter 7&nbsp;&nbsp;&nbsp;Cloning and Mutagenesis Market Size and Forecast, By End-use (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by end-use

7.2&nbsp;&nbsp;&nbsp; Biotechnology &amp; pharmaceutical companies

7.3&nbsp;&nbsp;&nbsp; CROs &amp; CDMOs

7.4&nbsp;&nbsp;&nbsp; Academic &amp; research institutes

Chapter 8&nbsp;&nbsp;&nbsp;Cloning and Mutagenesis Market Size and Forecast, By Region (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by region

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; Japan

8.4.2&nbsp;&nbsp;&nbsp; China

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

8.6&nbsp;&nbsp;&nbsp; MEA

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; Rest of MEA

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Agilent Technologies, Inc.

9.2&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific, Inc.

9.3&nbsp;&nbsp;&nbsp; Takara Bio Inc.

9.4&nbsp;&nbsp;&nbsp; Merck KGaA

9.5&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories, Inc.

9.6&nbsp;&nbsp;&nbsp; Danaher

9.7&nbsp;&nbsp;&nbsp; Jena Bioscience GmbH

9.8&nbsp;&nbsp;&nbsp; New England Biolabs

9.9&nbsp;&nbsp;&nbsp; Promega Corporation

9.10&nbsp;&nbsp;&nbsp; Assay Genie

9.11&nbsp;&nbsp;&nbsp; TransGen Biotech Co., Ltd.

9.12&nbsp;&nbsp;&nbsp; GenScript

9.13&nbsp;&nbsp;&nbsp; Genomax Technologies Pte Ltd

9.14&nbsp;&nbsp;&nbsp; Genes2Me 
&nbsp;

Cloning and Mutagenesis Market

Get a free sample of this report